ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,121.24
-0.28%
Dow Jones
37,903.29
0.23%
Gold vs US Dollar
2,320.885
-0.15%
Brent Oil
83.905
0.44%
Bitcoin
57,451.45
-1.35%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Pharma Equity Group A/s (0REU)

  7. Pharma Equity Group A/s (0REU) News

Pharma Equity Group A/s (0REU)

Pharma Equity Group A/s
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0REU
DateTimeSourceHeadlineSymbolCompany
23/04/202410:45UK RegulatoryMajor shareholder announcement - Pharma Equity Group A/SLSE:0REUPharma Equity Group A/s
16/04/202416:29UK RegulatoryPassing of the General Meeting of Pharma Equity Group A/SLSE:0REUPharma Equity Group A/s
10/04/202413:21UK RegulatoryThe Board of Director's decision to issue convertible loansLSE:0REUPharma Equity Group A/s
05/04/202410:22UK RegulatoryPharma Equity Group’s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company’s patented drug candidate RNX-051.LSE:0REUPharma Equity Group A/s
25/03/202412:06UK RegulatoryNotice convening the annual general meeting in Pharma Equity Group A/SLSE:0REUPharma Equity Group A/s
22/03/202408:00UK RegulatoryPharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK0061155009LSE:0REUPharma Equity Group A/s
21/03/202415:32UK RegulatoryCompletion of subscription of convertible loansLSE:0REUPharma Equity Group A/s
20/03/202407:58UK RegulatoryPharma Equity Group A/S - Annual Report 2023LSE:0REUPharma Equity Group A/s
05/03/202409:11UK RegulatoryPharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for promoting the healing of wounds (RNX-022).LSE:0REUPharma Equity Group A/s
07/02/202412:38UK RegulatoryCompletion of subscription of convertible loansLSE:0REUPharma Equity Group A/s
07/02/202408:46UK RegulatoryThe Board of Director's decision to issue convertible loansLSE:0REUPharma Equity Group A/s
25/01/202409:08UK RegulatoryCompletion of subscription of convertible loansLSE:0REUPharma Equity Group A/s
 Showing the most relevant articles for your search:LSE:0REU

Your Recent History

LSE
JAY
Bluejay Mining
LSE
BARC
Barclays
LSE
GGP
Greatland Gold
LSE
GROW
Molten Ventures
LSE
FMET
Fulcrum Metals
LSE
BNN
BNN Technology
LSE
VLX
Volex
LSE
VAST
Vast Resources
LSE
EDEN
Eden Research
LSE
XTR
Xtract Resources
LSE
IES
Invinity Energy Systems
LSE
EEE
Empire Metals
LSE
BIRD
Blackbird
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved